Tokyo, May 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061458) titled 'A Prospective Observational Study on the Effect of Spacer (PARI Vortex) Use in Patients with Residual Symptoms Receiving Triple Inhalation Therapy with Budesonide/Glycopyrronium/Formoterol' on May 6.
Study Type:
Observational
Primary Sponsor:
Institute - Other
Condition:
Condition - chronic obstructive pulmonary disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The efficacy of spacer use (PARI Vortex) will be evaluated in patients aged 40 years or older with COPD who have persistent symptoms despite triple inhalation therapy with budesonide/glycopyrronium/form...